Stabilization of Angiotensin-(1-7) in Cardioprotective Solutions

Miriam Russ,Susanne Jauk,Reinhold Wintersteiger,Bernd Gesslbauer,Joachim Greilberger,Michaela Andrä,Astrid Ortner
DOI: https://doi.org/10.1007/s10989-018-9773-y
2018-10-12
International Journal of Peptide Research and Therapeutics
Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Angiotensin-(1-7) (Ang 1-7) has been previously studied in combination with an antioxidant containing preparation as a cardioprotective reperfusion solution. In this study a stability improvement of aqueous Ang 1-7 solutions was observed. However, no data was provided on the responsibilities and causes of the noticed stability enhancement. Therefore, the influence of pH and pharmaceutical additives as well as the effect of the single specific agents present in the antioxidant preparation such as α-ketoglutaric acid (α-KG), 5-hydroxymethylfurfural (5-HMF), <em class="a-plus-plus">N</em>-acetyl-seleno-<span class="a-plus-plus emphasis type-small-caps">l</span>-methionine (NASeLM) and <em class="a-plus-plus">N</em>-acetyl-<span class="a-plus-plus emphasis type-small-caps">l</span>-methionine (NALM) on the stability was evaluated. Analyses were performed by an HPLC method with fluorescence detection. Crucial instability was found in a pH range of 5.0–7.5 without addition of the antioxidative mixture. Zetasizing confirmed the presence of microparticles and MS studies showed no degradation products within 25 days. 5-HMF was identified as main component for stability enhancement of Ang 1-7 solution. By adding this substance the stability of the cardioprotective peptide solution can be prolonged and appears as a promising approach for transplant purposes.</p>
biochemistry & molecular biology
What problem does this paper attempt to address?